Midaglizole ((±)-DG5128 free base, DG5128 free base) is a potent α2-adrenoceptor antagonist. Midaglizole is a hypoglycemic agent. Midaglizole increases blood pressure and reduces blood glucose levels in vivo.
性状
Solid
体外研究(In Vitro)
Midaglizole stimulates insulin release with the EC50 values of 200 nM, 24 μM for rat islets and MIN6 β-cell line, respectively. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
Midaglizole (3, 30 mg/kg; i.v.) increases blood pressure in rats.
Midaglizole (0.2, 1, 2 mg/kg; infusion) reduces blood glucose levels in dags. has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model:
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
参考文献
[1]. Hirohashi M, et al. Intrinsic pressor activity of midaglizole, an alpha-2 adrenoceptor antagonist, in pithed rats. Jpn J Pharmacol. 1990 Aug;53(4):519-20. [2]. Ohneda K, et al. Mechanism of insulin secretion by midaglizole. Diabetes Res Clin Pract. 1993 Feb;19(2):127-32.[3]. Proks P, et al. Inhibition of reco
溶解度数据
In Vitro: DMSO : 162.5 mg/mL (646.56 mM; Need ultrasonic)配制储备液
[1]. Hirohashi M, et al. Intrinsic pressor activity of midaglizole, an alpha-2 adrenoceptor antagonist, in pithed rats. Jpn J Pharmacol. 1990 Aug;53(4):519-20. [2]. Ohneda K, et al. Mechanism of insulin secretion by midaglizole. Diabetes Res Clin Pract. 1993 Feb;19(2):127-32.[3]. Proks P, et al. Inhibition of reco